International Clinical Trial: Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821398) titled 'Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis' on Sept. 10.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Bastiaan Driehuys

Condition: Interstitial Lung Disease Pulmonary Hypertension Systemic Sclerosis

Intervention: Drug: Hyperpolarized 129 Xenon Gas

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: November 1, 2026

Target Sample Size: 51

To know more, visit https://clinicalt...